{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:06:45Z","timestamp":1750910805561,"version":"3.41.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.soc.2024.12.001","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T20:48:46Z","timestamp":1736282926000},"page":"227-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Prophylactic or Adjuvant Hyperthermic Intraperitoneal Therapy in Appendiceal and Colorectal Cancer Peritoneal Metastasis"],"prefix":"10.1016","volume":"34","author":[{"given":"Monique H.","family":"Gandawidjaja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belain","family":"Eyob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Chmiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver S.","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.soc.2024.12.001_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.soc.2024.12.001_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","article-title":"Mechanisms of metastatic colorectal cancer","volume":"21","author":"Ca\u00f1ellas-Socias","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"20","key":"10.1016\/j.soc.2024.12.001_bib3","article-title":"Unexpected and rare sites of metastasis in oncologic patients","volume":"12","author":"Shalata","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.soc.2024.12.001_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.soc.2024.12.001_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpainsymman.2010.05.007","article-title":"Malignant bowel obstruction: natural history of a heterogeneous patient population followed prospectively over two years","volume":"41","author":"Chakraborty","year":"2011","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"5","key":"10.1016\/j.soc.2024.12.001_bib6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","article-title":"Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study","volume":"47","author":"Lurvink","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.12.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-32198-z","article-title":"Molecular characterization of colorectal cancer related peritoneal metastatic disease","volume":"13","author":"Lenos","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.soc.2024.12.001_bib8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1245\/s10434-016-5732-z","article-title":"Survival and prognostic factors for metachronous peritoneal metastasis in patients with colon cancer","volume":"24","author":"Nagata","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.12.001_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2024.12.001_bib10","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/bjs.10527","article-title":"Evaluation of the peritoneal carcinomatosis index with CT and MRI","volume":"104","author":"Dohan","year":"2017","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.soc.2024.12.001_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1245\/s10434-012-2473-5","article-title":"Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review","volume":"20","author":"Honor\u00e9","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2024.12.001_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02656736.2017.1306119","article-title":"Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer?","volume":"33","author":"Honor\u00e9","year":"2017","journal-title":"Int J Hyperthermia"},{"issue":"12","key":"10.1016\/j.soc.2024.12.001_bib13","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.soc.2024.12.001_bib14","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.3390\/cancers15235641","article-title":"Peritoneal metastasis: a dilemma and challenge in the treatment of metastatic colorectal cancer","volume":"15","author":"Xia","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.soc.2024.12.001_bib15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1245\/s10434-020-08316-w","article-title":"The Chicago Consensus on peritoneal surface malignancies: management of appendiceal neoplasms","volume":"27","author":"Schuitevoerder","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2024.12.001_bib16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1634\/theoncologist.2017-0081","article-title":"Appendiceal mucinous neoplasms: diagnosis and management","volume":"22","author":"Shaib","year":"2017","journal-title":"Oncol"},{"issue":"41","key":"10.1016\/j.soc.2024.12.001_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/EDBK_321009","article-title":"Current management of appendiceal neoplasms","volume":"41","author":"Hoehn","year":"2021","journal-title":"Am Soc Clin Oncol Educ book Am Soc Clin Oncol Annu Meet"},{"issue":"9","key":"10.1016\/j.soc.2024.12.001_bib18","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2024.12.001_bib19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/SLA.0b013e31827e9289","article-title":"Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?","volume":"257","author":"Go\u00e9r\u00e9","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2024.12.001_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221112478","article-title":"The role of chemotherapy in the treatment of advanced appendiceal cancers: summary of the literature and future\u00a0directions","volume":"14","author":"Strach","year":"2022","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"10.1016\/j.soc.2024.12.001_bib21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jamcollsurg.2017.12.027","article-title":"A\u00a0multicenter randomized trial to evaluate hematologic toxicities after hyperthermic intraperitoneal chemotherapy with oxaliplatin or mitomycin in patients with appendiceal tumors","volume":"226","author":"Levine","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2","key":"10.1016\/j.soc.2024.12.001_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.12.001_bib23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.soc.2024.12.001_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejso.2022.07.019","article-title":"Patterns and timing of recurrence following CRS and HIPEC in colorectal cancer peritoneal metastasis","volume":"49","author":"Hassan","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2024.12.001_bib25","doi-asserted-by":"crossref","first-page":"108294","DOI":"10.1016\/j.ejso.2024.108294","article-title":"Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"50","author":"Dietz","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.12.001_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00261-007-9211-7","article-title":"Staging of peritoneal carcinomatosis: enhanced CT vs. PET\/CT","volume":"33","author":"Dromain","year":"2008","journal-title":"Abdom Imaging"},{"issue":"3","key":"10.1016\/j.soc.2024.12.001_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jso.25967","article-title":"Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer","volume":"122","author":"Chen","year":"2020","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.12.001_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/pp-2017-0010","article-title":"Pharmacological principles of intraperitoneal and bidirectional chemotherapy","volume":"2","author":"De Bree","year":"2017","journal-title":"Pleura and peritoneum"},{"issue":"5","key":"10.1016\/j.soc.2024.12.001_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/02656730701455318","article-title":"Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy","volume":"23","author":"Sugarbaker","year":"2007","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"10.1016\/j.soc.2024.12.001_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SLA.0b013e3182193143","article-title":"Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model","volume":"254","author":"Pich\u00e9","year":"2011","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.soc.2024.12.001_bib31","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.3390\/cancers13133114","article-title":"Hyperthermic intraperitoneal chemotherapy: a critical review","volume":"13","author":"Ceelen","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.soc.2024.12.001_bib32","doi-asserted-by":"crossref","first-page":"e2004788","DOI":"10.1002\/adma.202004788","article-title":"Recent advances in hyperthermia therapy-based synergistic immunotherapy","volume":"33","author":"Chang","year":"2021","journal-title":"Adv Mater"},{"issue":"8","key":"10.1016\/j.soc.2024.12.001_bib33","doi-asserted-by":"crossref","first-page":"e2400149","DOI":"10.1200\/PO.24.00149","article-title":"Mutational features and tumor microenvironment alterations in high-grade appendiceal cancers treated with iterative hyperthermic intraperitoneal chemotherapy","volume":"8","author":"Su","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"10.1016\/j.soc.2024.12.001_bib34","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","article-title":"Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer","volume":"203","author":"da Silva","year":"2006","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.soc.2024.12.001_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7800-2-3","article-title":"Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer","volume":"2","author":"Harmon","year":"2005","journal-title":"Int Semin Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.12.001_bib36","first-page":"149","article-title":"Routine second-look after surgical treatment of colonic peritoneal carcinomatosis","volume":"152","author":"Delhorme","year":"2015","journal-title":"J\u00a0Visc Surg"},{"issue":"2","key":"10.1016\/j.soc.2024.12.001_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/SLA.0b013e31822638f6","article-title":"Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis","volume":"254","author":"Elias","year":"2011","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.soc.2024.12.001_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ciresp.2017.11.006","article-title":"Systematic second-look surgery plus HIPEC in patients without evidence of recurrence, at high risk of carcinomatosis after colorectal cancer resection","volume":"96","author":"Serrano del Moral","year":"2018","journal-title":"Cir Esp"},{"issue":"9","key":"10.1016\/j.soc.2024.12.001_bib39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"Go\u00e9r\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.soc.2024.12.001_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00134-0","article-title":"Limitations of the PRODIGE 7 trial","volume":"22","author":"Str\u00f6hlein","year":"2021","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.12.001_bib41","doi-asserted-by":"crossref","first-page":"zraa075","DOI":"10.1093\/bjsopen\/zraa075","article-title":"Effect of oxaliplatin-based chemotherapy on chemosensitivity in patients with peritoneal metastasis from colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: proof-of-concept study","volume":"5","author":"Prabhu","year":"2021","journal-title":"BJS open"},{"issue":"34","key":"10.1016\/j.soc.2024.12.001_bib42","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.3748\/wjg.v22.i34.7692","article-title":"Pathophysiology of colorectal peritoneal carcinomatosis: role of the peritoneum","volume":"22","author":"Lemoine","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"20","key":"10.1016\/j.soc.2024.12.001_bib43","first-page":"6443","article-title":"The role of prophylactic and adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention of peritoneal metastases in advanced colorectal cancer","volume":"12","author":"Sun","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.soc.2024.12.001_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejca.2016.07.002","article-title":"Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: results of a population-based study","volume":"65","author":"Razenberg","year":"2016","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.soc.2024.12.001_bib45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial","volume":"4","author":"Klaver","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.soc.2024.12.001_bib46","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamaoncol.2019.0512","article-title":"Prognostic potential of circulating tumor DNA measurement in postoperative surveillance of nonmetastatic colorectal cancer","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.12.001_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1245\/s10434-022-12399-y","article-title":"Circulating tumor DNA is unreliable to detect somatic gene alterations in gastrointestinal peritoneal carcinomatosis","volume":"30","author":"Sullivan","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2024.12.001_bib48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/SLA.0000000000005856","article-title":"Role of tumor-informed personalized circulating tumor DNA assay in informing recurrence in patients with peritoneal metastases from colorectal and high-grade appendix cancer undergoing curative-intent surgery","volume":"278","author":"Dhiman","year":"2023","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.soc.2024.12.001_bib49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamasurg.2023.0662","article-title":"Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial","volume":"158","author":"Arjona-S\u00e1nchez","year":"2023","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.soc.2024.12.001_bib50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.2042-7158.1994.tb03883.x","article-title":"Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy","volume":"46","author":"KUZUYA","year":"1994","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"5","key":"10.1016\/j.soc.2024.12.001_bib51","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.eururo.2004.06.009","article-title":"The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines","volume":"46","author":"Van Der Heijden","year":"2004","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.soc.2024.12.001_bib52","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1245\/s10434-012-2238-1","article-title":"Importance of histologic subtype in the staging of appendiceal tumors","volume":"19","author":"Turaga","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2024.12.001_bib53","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/his.13324","article-title":"The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei","volume":"71","author":"Carr","year":"2017","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.soc.2024.12.001_bib54","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1245\/ASO.2006.03.079","article-title":"Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy","volume":"13","author":"Sugarbaker","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2024.12.001_bib55","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1634\/theoncologist.2014-0294","article-title":"Hyperthermic intraperitoneal chemotherapy following cytoreductive surgery improves outcome in patients with primary appendiceal mucinous adenocarcinoma: a pooled analysis from three tertiary care centers","volume":"20","author":"Shaib","year":"2015","journal-title":"Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.12.001_bib56","doi-asserted-by":"crossref","first-page":"e206363","DOI":"10.1001\/jamasurg.2020.6363","article-title":"The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery","volume":"156","author":"Kusamura","year":"2021","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.soc.2024.12.001_bib57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/02656736.2016.1152514","article-title":"Prophylactic hyperthermic intraperitoneal chemotherapy in patients with epithelial appendiceal neoplasms","volume":"32","author":"Tuvin","year":"2016","journal-title":"Int J Hyperthermia"},{"issue":"7","key":"10.1016\/j.soc.2024.12.001_bib58","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/bjs.8739","article-title":"Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms","volume":"99","author":"McDonald","year":"2012","journal-title":"Br J Surg"},{"issue":"11","key":"10.1016\/j.soc.2024.12.001_bib59","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/DCR.0000000000000869","article-title":"Peritoneal involvement is more common than nodal involvement in patients with high-grade appendix tumors who are undergoing prophylactic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"60","author":"Mehta","year":"2017","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.soc.2024.12.001_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1245\/s10434-019-07634-y","article-title":"Outcomes after adjuvant hyperthermic intraperitoneal chemotherapy for high-risk primary appendiceal neoplasms after complete resection","volume":"27","author":"Enomoto","year":"2020","journal-title":"Ann Surg Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:46:30Z","timestamp":1750862790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320724000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1055320724000875"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2024.12.001","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Prophylactic or Adjuvant Hyperthermic Intraperitoneal Therapy in Appendiceal and Colorectal Cancer Peritoneal Metastasis","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}